Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated ...

Breaking 84 years of tradition, Robbie Gries made history as AAPG's first female president (2001-02). “I was honored to represent women in that breakthrough,” Robbie Gries says of being named the ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Ascentage Pharma Group Internat (NASDAQ:AAPG) stands against ...

EDITOR’S NOTE: In the March issue of OGFJ (Editor’s comment, "A baffling choice"), we take the American Association of Petroleum Geologists to task for giving novelist Michael Crichton, a ...

) has been revised to $30.72 / share. This is a decrease of 13.66% from the prior estimate of $35.58 dated December 20, 2025. The price target is an average of many targets provided by analysts. The ...

Fintel reports that on November 10, 2025, BTIG initiated coverage of Ascentage Pharma Group International - Depositary Receipt (NasdaqGM:AAPG) with a Buy recommendation. As of November 9, 2025, the ...

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company’s ...